(VIANEWS) – Shares of Genmab (NASDAQ: GMAB) rose by a staggering 22.79% in 14 days from $26.72 to $32.81 at 14:13 EST on Thursday, following the last session’s upward trend. NASDAQ is sliding 0.68% to $11,102.01, after three successive sessions in a row of losses.
Genmab’s last close was $31.76, 35.28% under its 52-week high of $49.07.
Today’s last reported volume for Genmab is 314636 which is 53.86% below its average volume of 682051.
Genmab’s sales growth is a negative 63.6% for the current quarter and 35.3% for the next.
Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 8.48B for the twelve trailing months.
Genmab’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.17%, a positive 0.21%, and a positive 2.08%, respectively.
Genmab’s highest amplitude of average volatility was 2.25% (last week), 2.34% (last month), and 2.08% (last quarter), respectively.
Genmab’s Stock Yearly Top and Bottom Value
Genmab’s stock is valued at $32.81 at 14:13 EST, way below its 52-week high of $49.07 and way above its 52-week low of $26.19.
Genmab’s Moving Average
Genmab’s worth is higher than its 50-day moving average of $31.66 and way below its 200-day moving average of $36.86.
More news about Genmab (GMAB).